Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Non Operating Interest Expenses (2009 - 2023)

Evotec SE's (EVO) quarterly Non Operating Interest Expenses came in at -$2.8 million in Q2 2023, up 29.31% year-over-year from -$2.1 million in Q2 2022, and up 86.88% quarter-over-quarter from -$21.1 million in Q4 2022.

Analysis

Evotec SE (EVO) Non Operating Interest Expenses (2009 - 2023) Analysis & Trends

Evotec SE has disclosed Non Operating Interest Expenses across 7 years of filings, most recently posting -$2.8 million for Q2 2023.

  • In Q2 2023, Non Operating Interest Expenses rose 29.31% year-over-year to -$2.8 million; the TTM figure through Jun 2023 stood at -$24.7 million (down 25.74% YoY), while the FY2022 annual figure was -$13.9 million, down 26.56% from the prior year.
  • Non Operating Interest Expenses came in at -$2.8 million for Q2 2023 at Evotec SE, up from -$21.1 million in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $3.1 million in Q3 2022 to a low of -$21.1 million in Q4 2022.
  • Average Non Operating Interest Expenses over 5 years is -$5.1 million, with a median of -$3.4 million recorded in 2021.
  • Year-over-year, Non Operating Interest Expenses tumbled 139.46% in 2020 and surged 339.69% in 2021.
  • Over 5 years, Non Operating Interest Expenses stood at -$4.6 million in 2019, then plunged by 139.46% to -$11.1 million in 2020, then declined by 20.39% to -$13.3 million in 2021, then tumbled by 57.99% to -$21.1 million in 2022, then soared by 86.88% to -$2.8 million in 2023.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$2.8 million in Q2 2023, -$21.1 million in Q4 2022, and $3.1 million in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 197.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 30.34 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -48.79 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn -
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -3,647.53
10 VivoSim Labs 1.45 Mn 1.45 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -2.77 Mn
Dec 31, 2022 -21.09 Mn
Sep 30, 2022 3.08 Mn
Jun 30, 2022 -3.91 Mn
Mar 31, 2022 -4.66 Mn
Dec 31, 2021 -13.35 Mn
Sep 30, 2021 2.29 Mn
Jun 30, 2021 -2.39 Mn
Mar 31, 2021 -2.79 Mn
Dec 31, 2020 -11.09 Mn
Sep 30, 2020 519,794.37
Dec 31, 2019 -4.63 Mn
Sep 30, 2010 -85,223.99
Jun 30, 2010 178,477.25
Mar 31, 2010 -139,855.69
Dec 31, 2009 -265,812.16
Jun 30, 2009 122,548.35
Mar 31, 2009 214,468.30